| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/12/2011 | EP2271358A2 Neurodegenerative disorders |
| 01/12/2011 | EP2271355A2 Use of prokaryotic tir-domain containing proteins as therapeutic and diagnostic agents |
| 01/12/2011 | EP2027156B1 Hepatocyte growth factor (hgf) binding proteins |
| 01/12/2011 | EP1951296B1 Cell-derived viral vaccines with low levels of residual cell dna |
| 01/12/2011 | EP1865058B1 Anti-cd-20 monoclonal antibody |
| 01/12/2011 | EP1704167B1 A method to make a peptide-carrier conjugate with a high immunogenicity |
| 01/12/2011 | EP1660524B1 Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases |
| 01/12/2011 | EP1644034B1 Composition for enhancing an immune response comprising packaged virus-like particles |
| 01/12/2011 | EP1613341B1 Use of slurp-1 for treating diseases related to acetylcholine receptors dysfunction |
| 01/12/2011 | EP1578443B1 Compositions comprising antigen-complexes, method for making same as well as methods of using the antigen-complexes for vaccination |
| 01/12/2011 | EP1439863B1 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 01/12/2011 | EP1221972B1 Plant lectins as mucosal adjuvants |
| 01/12/2011 | EP0821736B1 Bacteriocins |
| 01/12/2011 | CN1791614B Construct comprising recognition domain of antibody against von Willebrand factor-specific cleaving enzyme |
| 01/12/2011 | CN1738595B Composition comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters |
| 01/12/2011 | CN1688605B Novel immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes |
| 01/12/2011 | CN1675245B Monoclonal antibody hPAM4 |
| 01/12/2011 | CN101946003A Anti-adam-15 antibodies and utilization of the same |
| 01/12/2011 | CN101945893A Anti-human nkg2d monoclonal antibodies and use thereof |
| 01/12/2011 | CN101945892A Methods and agents for improving targeting of cd138 expressing tumor cells |
| 01/12/2011 | CN101945891A Methods for the treatment of gout |
| 01/12/2011 | CN101945667A Therapy of rituximab-refractory rheumatoid arthritis patients |
| 01/12/2011 | CN101945666A Compositions and methods for treatment of autoimmune and allergic diseases |
| 01/12/2011 | CN101942419A Dog parvovirus attenuated vaccine strain and application thereof |
| 01/12/2011 | CN101942418A 333rd amino acid mutant strain of rabies virus Flury-LEP glycoprotein |
| 01/12/2011 | CN101942417A Separated bacteriophages of enterobacter sakazakii, combination and application thereof |
| 01/12/2011 | CN101942020A Streptavidin/interleukin-7 fusion protein |
| 01/12/2011 | CN101942017A Novel tumor marker |
| 01/12/2011 | CN101942013A HLA-DR9 restrictive regulatory T cell epitope of Hepatitis B virus core antigen and e antigen and application thereof |
| 01/12/2011 | CN101942011A Neutralizing epitope of human adenovirus type 3 (HAdV-3) and type 7 (HAdV-7) and application thereof |
| 01/12/2011 | CN101940794A Csk binding protein inhibitor and application thereof |
| 01/12/2011 | CN101940787A Adjuvant for improving effect of porcine reproductive and respiratory syndrome inactivated vaccine, preparation method thereof and application thereof |
| 01/12/2011 | CN101940786A Application of immunogenic protein gene PilA of haemophilus parasuis |
| 01/12/2011 | CN101940550A Preparation method of gonadotropin releasing hormone liposome |
| 01/12/2011 | CN101940189A Transgenic trasnchromosomal rodents for making human antibodies |
| 01/12/2011 | CN101560503B Influenza A virus Vero cell adapted strain and application thereof |
| 01/12/2011 | CN101450206B Production method of Escherichia coli K88, K99, 987P cilia subunit oil-emulsion vaccine |
| 01/12/2011 | CN101081863B Lipopolysaccharide conjugated protein and monoclonal antibody and usage |
| 01/11/2011 | US7868141 Anti-OX40L antibodies |
| 01/11/2011 | US7868140 Human anti-B7RP1 neutralizing antibodies |
| 01/11/2011 | US7868133 For diagnosis, treatment, and prevention of apoptosis associated disorders using animal models; for drug screening; chimeras; genetic engineering, cancer |
| 01/11/2011 | US7867982 administering to a primate(human) an immunogenic composition containing modified virus Ankara (MVA), a replication-deficient strain of vaccinia virus, expressing human immunodeficiency virus (HIV) env, gag, and pol genes to induce a CD8+T cell immune |
| 01/11/2011 | US7867764 replication-defective recombinant adenovirus comprising a heterologous nucleic acid sequence encoding an antigenic determinant of Plasmodium falciparum that comprises an immunogenic peptide of the circumsporozoite protein; viral vectors |
| 01/11/2011 | US7867729 Drug screening; assay for aldehyde dehydrogenase activity; cancer |
| 01/11/2011 | US7867715 Determining effectivenss of immunoglobulin binding; immunoassay; vaccine efficacy; immunodiagnostics and allergies |
| 01/11/2011 | US7867704 for detecting Mycobacterium paratuberculosis in a sample using nucleic acid molecules, polypeptides, and antibodies; for immunization and prevention of mycobacterial animal infections |
| 01/11/2011 | US7867503 Using granule antigen protein (GRA6) specific immunoglobulin for diagnosis, prevention and treatment of parasitic infection |
| 01/11/2011 | US7867502 Genetic engineered polypeptides; useful candidates in a vaccine against tuberculosis (TB) or diagnostic preparation for TB; vaccine; inhibit mycobacterial virulence |
| 01/11/2011 | US7867501 polypeptides derived from Streptococcus pneumoniae including surface or secreted proteins or parts thereof, that are useful as molecular targets for diagnostics, prophylaxis and treatment of bacterial infection; vaccines |
| 01/11/2011 | US7867500 A carrier and a steroid receptor coactivator-1 and transcription intermediary factor-2 Associated Modulatory Protein (STAMP) that can modulate transcription of glucocorticoid-, progesterone-, mineralocorticoid- and androgen-responsive genes; conception (contraception), infertility, diabetes, cancer etc |
| 01/11/2011 | US7867499 VLP structure chemically coupled to a fragment of the A beta -1-42 peptide; Alzheimer's and Parkinson's disease |
| 01/11/2011 | US7867498 comprise at least five CD4+ T cell epitopes, for conjugation to capsular polysaccharides; for use in treatment and prevention of plasmodial infection; genetic vaccines; for immunization |
| 01/11/2011 | US7867497 Monoclonal antibodies to respiratory syncytial virus and uses therefor |
| 01/11/2011 | US7867496 Use of TGF-β antagonists to limit nephrotoxicity of immunosuppressive agents |
| 01/11/2011 | US7867495 for inflammatory diseases such as rheumatoid arthritis; GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor); |
| 01/11/2011 | US7867494 Anti-IgE antibodies |
| 01/11/2011 | US7867493 for preventing and treating cancer; kits; Prolactin receptor (PRLR) |
| 01/11/2011 | US7867491 hybrid Fc; useful as a carrier of biologically active molecules |
| 01/11/2011 | US7867490 Treatment of liver cirrhosis and its complications |
| 01/11/2011 | US7867488 Use of dendritic cells (DCs) expressing interleukin 12 (IL-12) |
| 01/11/2011 | US7867481 Method of treating anemia by administering IL-1ra |
| 01/11/2011 | US7867480 Non-invasive vaccination through the skin |
| 01/11/2011 | US7867475 Using NK gene complex family of type II oligomeric signal transmitting receptor proteins containing C-type lectin-binding domain; increasing tumor necrosis factor alpha production; autoimmune diseases |
| 01/11/2011 | CA2377479C Compositions and methods for preventing transepithelial transmission of hiv |
| 01/11/2011 | CA2349406C Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
| 01/11/2011 | CA2286313C Novel ldl-receptor |
| 01/11/2011 | CA2263848C New systems for the regulation of gene expression |
| 01/11/2011 | CA2218764C Vaccine composition containing polyribosylribitol phosphate and method for making same |
| 01/10/2011 | CA2709340A1 Mutations in the influenza a virus ns1 gene and use thereof |
| 01/06/2011 | WO2011003100A2 Compositions and methods for diagnosing and/or treating influenza infection |
| 01/06/2011 | WO2011003071A1 Methods of modulating hepatitis c virus infection |
| 01/06/2011 | WO2011003062A2 Probiotic compositions and processes thereof |
| 01/06/2011 | WO2011002968A2 Polypeptides and method of treatment |
| 01/06/2011 | WO2011002852A2 Pro-drug complexes and related methods of use |
| 01/06/2011 | WO2011002836A2 Attenuated enterohemorrhagic e.coli-based vaccine vector and methods relating thereto |
| 01/06/2011 | WO2011002494A1 Use of immunoglobulin heavy and light chains or fragments therof to bind to aggregated amyloidogenic proteins |
| 01/06/2011 | WO2011001882A1 Flagellin mutant capable of effectively inducing protective capability on infection by pseudomonas aeruginosa |
| 01/06/2011 | WO2011001276A1 Immunocytokines in combination with anti-erbb antibodies for the treatment of cancer |
| 01/06/2011 | WO2011000962A2 Novel therapeutic and diagnostic means |
| 01/06/2011 | WO2011000889A1 Topical vaccine formulations and methods of treating drug addiction using same |
| 01/06/2011 | WO2011000860A2 Targets for retrovirus associated diseases |
| 01/06/2011 | WO2011000551A1 Exosome based treatment of cancer |
| 01/06/2011 | WO2011000384A1 Method for suppressing tumor growth by blocking fibroblast growth factor receptor, and method for diagnosing malignant neoplasms |
| 01/06/2011 | WO2011000095A1 Multimeric peptide conjugates and uses thereof |
| 01/06/2011 | WO2010132659A3 Anti-human cd52 immunoglobulins |
| 01/06/2011 | WO2010131009A3 Treatment of il-25 mediated diseases with tlr antagonists |
| 01/06/2011 | WO2010129917A3 Anti-cd100 antibodies and methods for using the same |
| 01/06/2011 | WO2010124218A3 Genetic variants in il-6, p53, mmp-9 and cxcr predict clinical outcome in patients with cancer treated with anti-vegf therapy |
| 01/06/2011 | WO2010120599A3 Compositions and methods for treating cancer |
| 01/06/2011 | WO2010119991A3 Anti-hgf antibody combinational cancer therapies |
| 01/06/2011 | WO2010115555A3 Antibodies against human tweak and uses thereof |
| 01/06/2011 | WO2010111633A3 Antibody composition with altered fab sialylation |
| 01/06/2011 | WO2010104761A3 Anti-cd40 antibodies and uses thereof |
| 01/06/2011 | WO2010101750A3 Attenuated salmonella enterica serovar paratyphi a and uses thereof |
| 01/06/2011 | WO2010099444A3 Modified live aeromonas hydrophila vaccine for aquatic animals |
| 01/06/2011 | WO2010099432A3 Recognition of cyp2e1 epitopes |
| 01/06/2011 | WO2010098613A3 Tm7sf3 composition for diagnosing liver cancer, diagnostic kit containing anti-tm7sf3 antibodies, and pharmaceutical composition for preventing or treating liver cancer |
| 01/06/2011 | WO2010092479A3 Influenza vaccines with reduced amounts of squalene |
| 01/06/2011 | WO2010090758A3 Diabetes diagnostic, prophylactic, and therapeutic compositions and methods |
| 01/06/2011 | WO2010088691A3 Compositions and methods for treating or preventing conditions and diseases associated with mannheimia haemolytica |